Compare SAVA & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAVA | TORO |
|---|---|---|
| Founded | 1998 | 2022 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.9M | 84.0M |
| IPO Year | N/A | N/A |
| Metric | SAVA | TORO |
|---|---|---|
| Price | $2.29 | $4.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 863.6K | 123.8K |
| Earning Date | 03-02-2026 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $20,203,079.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $1.70 |
| 52 Week High | $4.98 | $6.15 |
| Indicator | SAVA | TORO |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 29.91 |
| Support Level | $1.97 | $3.61 |
| Resistance Level | $2.19 | $4.58 |
| Average True Range (ATR) | 0.11 | 0.36 |
| MACD | 0.05 | -0.23 |
| Stochastic Oscillator | 85.14 | 20.67 |
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.